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Bullous pemphigoid (BP) is the most common autoimmune blistering disease, and has been associated with many
diseases; most autoimmune. It has never previously been associated with a reperfused limb. A 74-year-old female
underwent a right femoroanterior tibial polytetrafluoroethylene (PTFE) bypass for tissue loss and rest pain in the right
foot. After surgery she was treated for recurrent infection which exacerbated tissue loss and was eventually diagnosed as
BP. There was a delay in diagnosis due to the similarity to dry gangrene. This case highlights the potential difficulties of
BP diagnosis in a revascularized limb and the importance of multidisciplinary management of atypical infection. (J Vasc
Surg 2010;51:732-4.)Bullous pemphigoid (BP) is an autoimmune subepider-
mal bullous disorder characterized by the deposition of
autoantibodies and complement in the basement mem-
brane zone.1 BP is observed primarily in the elderly popu-
lation and has a number of well described associations with
other diseases. These are mainly autoimmune and in-
clude rheumatoid arthritis, primary biliary cirrhosis, and
systemic lupus erythematosus. Many drugs have also been
associated with BP including furosemide, ibuprofen, and
other NSAIDs, captopril, penicillamine, and antibiotics.
However, BP has never previously been reported in the
revascularized portion of an ischemic limb. This report
describes the diagnostic challenge of such a case and re-
views treatment and possible pathologic mechanisms.
CASE REPORT
A 74-year-old Indian female underwent a right femoroante-
rior tibial polytetrafluoroethylene (PTFE) bypass for tissue loss
(third toe necrosis) and rest pain in the right foot. She was a type II
diabetic on insulin, hypertensive, and had two myocardial infarc-
tions previously. She had no history of autoimmune or previous
bullous disorders. Surgery and recovery were uneventful and no
new medications were started. She was discharged 1 week postop-
eratively and presented to her general practitioner (GP) 1 week
after with an episode diagnosed as cellulitis. The initial appearance
(before antibiotics were started) was of bullae with erythema. She
was treated with oral flucloxacillin at home which initially im-
proved the cellulitis, but infection recurred a fortnight later. The
blisters had not resolved, and at this stage she was admitted to the
hospital. The right foot was erythematous and warm to the fore-
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732foot and a ruptured blister was present at the base of the third toe.
Dry gangrene was present at the previously necrotic third toe.
Preoperative ankle-brachial pressure index (ABPI) on the right was
0.46 and postoperatively was 0.69. There was no pyrexia, the
neutrophil count was 7.2  109 cells/L, the c-reactive protein
level was 7 mg/L, and wound and blood cultures were subse-
quently reported as negative. Fluid from the bullae was not sent for
culture, but appeared sterile. Reperfusion edema and blistering with
superadded infection was suspected, and, therefore, she was treated
with intravenous amoxicillin and clavulanic acid (co-amoxiclav) and
discharged to finish the course orally after 48 hours.
She was reviewed 2 weeks later as an outpatient where the
ruptured blisters were still present but all other signs had resolved.
Duplex ultrasound scan confirmed normal graft function. How-
ever, 3 weeks after this (8 weeks after surgery), and after two
further unsuccessful courses of antibiotics from her GP, she was
readmitted with the appearance in Fig 1. There was pyrexia
(37.8°C) and blood profiles were similar to those previously. The
previous necrosis of the third toe had worsened, but the graft still
had perfect function on duplex ultrasound scan. Before she was
referred back to vascular surgery and after microbiology review,
staphylococcus aureus infection was suspected and intravenous
amoxicillin and clavulanic acid (co-amoxiclav) were recommenced.
After 3 days of nonresolution and subsequent vascular referral,
simple infection was felt to be unlikely. Dermatologists were
therefore involved. They suspected BP and performed punch
biopsy of the foot. This showed epidermis split from the underly-
ing dermis at the dermal-epidermal junction. The underlying
dermis showed collections of eosinophils along the junction which
were seen in a perivascular distribution. There were ‘Indian-file’
neutrophil alignments at the dermal-epidermal junction. This was
pathologically consistent with BP, which was subsequently con-
firmed with linear IgG deposits along the basement membrane
zone on immunofluorescent studies. Oral steroids (prednisolone
30 mg) and permanganate soaks were commenced. There was an
immediate response to this treatment (Fig 2), with complete
resolution after 2 months.
DISCUSSION
BP is the most common autoimmune blistering disease
and has previously been associated with increasing age,
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mune.1 Association with some of these disorders may be
coincidental,2 which is arguably the case here. The BP may
also have been the result of a dressing used in the commu-
nity of which we are unaware. BP has previously been
associated with the insertion of a PTFE graft; however, in
that report the eruption was directly over the material
rather than at the previously ischemic extremity.3 This was
not observed in this case and no new medications or
dressings were commenced. She was on multiple medica-
tions for diabetes and cardiac disease including aspirin 75
mg; however, none of these were started within 8 months
of the preoperative admission nor strongly associated with
BP. Additionally, BP lesions have a predisposition to occur
on the lower abdomen, groin, and flexor surfaces of the
extremities rather than distal limbs.1 In support of BP occur-
ring as a result of the bypass procedure, there is a potential
pathologic link between BP and ischemia/reperfusion.4,5
BP is associated with autoantibodies against two indepen-
dent protein antigens, BP230 and BP180. BP230 is thought
to link intracellular keratin intermediate filaments to trans-
membrane proteins including BP180.6 BP180 is a trans-
membrane spanning protein which helps anchor epithelial
cells to the underlying basement membrane. Breakdown
of these antigens as a result of the immune response in
BP results in the breakdown, and, therefore, blisters at
the dermal/epidermal junction. Immunoblotting and en-
zyme linked immunosorbent assay (ELISA) studies show
Fig 1. Appearances 6 weeks postoperatively.that all patients with BP have antibodies against BP180with antibodies toward BP230 occurring to a variable
extent.7 These are not routinely examined for the diagnosis
of BP in the United Kingdom. Patients with BP have
IgG1-complement-fixing autoantibodies that react with
multiple epitopes on both the extracellular and intracellular
domain of BP180. Autoantibodies to BP230 are primarily
IgG4 subtype, do not fix complement, do not correlate
with disease activity, and do not affect prognosis.7 Impor-
tantly, IgG1, which is present in all patients with BP, leads
to unregulated complement activation especially with the
production of C5a from C5.4 Extensive blistering has been
reported after intradermal injection of C5a in C5 deficient
mice,8 and ‘Knockout’ C5 deficient mice are immune from
developing BP.4
Unregulated complement activation also plays a major
role in ischemia/reperfusion (I/R) injury in several organs
such as the heart, intestine, and lung.9 This phenomenon is
associatedwith an increased productionofC5a fromC5 in the
immediate postreperfusion period.5,10 Murine anti-C5 anti-
body treatment attenuates tissue injury in a murine model of
gastrointestinal I/R,11 and multiple other animal models
show that anti-C5 and C5a treatments reduce I/R injury.
It may, therefore, be postulated that patients with
ischemic limbs are at risk of developing BP in the previously
ischemic area after revascularization as a result of comple-
ment activation. Despite this, BP is rarely diagnosed in a
patient with peripheral vascular disease (PVD). This may be
Fig 2. Appearances 12 days after diagnosis of bullous pemphi-
goid (BP) and treatment with oral steroids and permanganate
soaks.because BP is often benign and self limiting and may,
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nosed as reperfusion edema and blistering and recedes
without diagnosis. However, in an already necrotic area of
tissue, BP can exacerbate necrosis and predisposes the
patient to secondary infection. This infection may never
fully resolve or recur until the underlying BP is diagnosed,
as illustrated by this case. Graft infection would be another
catastrophic result of infection of an area of BP and might
only be avoided by early diagnosis. The classic appearance
of BP only became obvious at a relatively late stage in this
case and could potentially have led to more serious conse-
quences. Early involvement of dermatologists and biopsy
would, therefore, be prudent in atypical, recurrent, or
culture negative limb infections.
CONCLUSION
BP is an autoimmune subepidermal bullous disorder. It
has associations with many diseases which may be coinci-
dental; however, there is a pathologic link between com-
plement activation as seen in I/R injury and BP. This case
illustrates the difficulty in reaching a diagnosis of BP, the
potentially serious effects of BP in an ischemic limb, and the
importance of specialist vascular review of infection in
ischemic or revascularized limbs. A multidisciplinary ap-
proach to unusual or nonresolving infections in such pa-
tients is therefore crucial.
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